• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

522 Postmarket Surveillance Studies Database

  • Print
  • Share
  • E-mail
-
The FDA has the authority to require device manufacturers to perform postmarket surveillance under Section 522 of the Food, Drugs and Cosmetics (FD&C) Act, when questions are identified for devices that meet the statutory criteria. This database contains information about 522 Postmarket Surveillance Studies that have been required. This database allows you to search information about the postmarket surveillance requirements by manufacturer or device.

Learn more...

            

Postmarket Surveillance Study


 
Suggest Enhancement / Report Issue | export reports to excelExport to Excel
General
Study Status Study Pending
522 Number / Requirement Number PS200005 / PSS001
Date Current Plan Accepted  
Study Name Postmarket Surveillance Study
Root Document Number K191416 
General Study Protocol Parameters
Study Design Prospective Cohort Study
Data Source New Data Collection
Comparison Group Concurrent Control
Analysis Type Analytical
Study Population Adult: >21


Postmarket Surveillance Study Schedule

Report Schedule
Report
Date Due
FDA Receipt
Date
Applicant's Reporting Status
6 month report 12/05/2020 12/07/2020 On Time
12 month report 06/05/2021 06/07/2021 On Time
18 month report 12/05/2021    
24 month report 06/05/2022    


-
-